Moxifloxacin-d4 (hydrochloride) (Synonyms: BAY 12-8039-d4) |
| Katalog-Nr.GC47704 |
A neuropeptide with diverse biological activities
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: N/A
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Moxifloxacin-d4 is intended for use as an internal standard for the quantification of moxifloxacin by GC- or LC-MS. Moxifloxacin is a fluoroquinolone antibiotic that is active through multiple routes of administration.1 Formulations containing moxifloxacin have been used to treat bacterial infections associated with bronchitis, sinusitis, and other conditions.2,3,4
1.Takiff, H., and Guerrero, E.Current prospects for the fluoroquinolones as first-line tuberculosis therapyAntimicrob. Agents and Chemother.55(12)5421-5429(2011) 2.Dryden, M.S.Complicated skin and soft tissue infectionJ. Antimicrob. Chemother.65(Suppl 3)iii35-iii44(2010) 3.Karageorgopoulos, D.E., Giannopoulou, K.P., Grammatikos, A.P., et al.Fluoroquinolones compared with β-lactam antibiotics for the treatment of acute bacterial sinusitis: A meta-analysis of randomized controlled trialsCanad. M. A. J.178(7)845-854(2008) 4.Miravitlles, M.Moxifloxacin in the management of exacerbations of chronic bronchitis and COPDInt. J. Chron. Obstruct. Pulmon. Dis.2(3)191-204(2007)
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *